Demand for Unapproved Weight-Loss Drug Surges on Social Media
Unapproved compounded retatrutide is being sold online and promoted by influencers, prompting FDA warnings for illegal marketing and unsafe, misbranded products.
FDA warns Hims & Hers and other weight loss drugmakers to remove 'false and misleading' advertising | Fortune
FDA is targeting telehealth companies for promoting unofficial compounded versions of prescription drugs, warning against claims equating them to FDA-approved medications.